Ubiquitin specific peptidase (USP37) mediated effects in microscaffold-encapsulated cells: a comprehensive study on

Shreemoyee De1, Ravi Chauhan2, Mayank Singh2

  • 1Centre for Biomedical Engineering, Indian Institute of Technology Delhi Hauz Khas New Delhi 110016 India shreemoyee.de@iitd.ac.in sneetu@iitd.ac.in.

RSC Advances
|February 14, 2024
PubMed

Insights

A novel 3D cell culture system rapidly models cancer progression and tests ubiquitin specific peptidase 37 (USP37) as a therapeutic target. This system offers a superior alternative to 2D models for studying oncogene depletion and its effects on cancer cell growth and metastasis.

Area of Science:

  • Oncology
  • Biotechnology
  • Biomedical Engineering

Background:

  • Current two-dimensional (2D) in vitro cancer models offer limited predictive value for clinical outcomes due to their inability to replicate the complex tumor microenvironment.
  • Three-dimensional (3D) cell culture models show promise but often require extensive optimization and cell density adjustments, hindering rapid experimental application.
  • The deubiquitinating enzyme ubiquitin specific peptidase 37 (USP37) is implicated in cancer progression, yet its therapeutic targeting requires robust in vitro validation models.

Purpose of the Study:

  • To develop and validate a rapid 3D cell culture system for studying cancer progression and therapeutic targets.
  • To investigate the role of ubiquitin specific peptidase 37 (USP37) in cancer cell proliferation, migration, and epithelial-mesenchymal transition (EMT) using the developed 3D model.
  • To assess the utility of carbon dot pH nanosensors within the 3D system for real-time monitoring of cellular processes.

Main Methods:

  • Development of a novel, user-friendly 3D cell culture platform enabling rapid experimental setup.
  • Utilized sensitive carbon dot pH nanosensors for real-time monitoring of cellular behavior within the 3D model.
  • Investigated the effects of ubiquitin specific peptidase 37 (USP37) depletion on cancer cell lines using both the novel 3D system and traditional 2D models.
  • Assessed changes in cancer cell growth, migration, and epithelial-mesenchymal transition (EMT) markers.

Main Results:

  • The developed 3D cell culture system demonstrated significantly faster experimental throughput compared to existing commercial models.
  • Depletion of ubiquitin specific peptidase 37 (USP37) in cancer cell lines led to reduced proliferation and migration, as observed in the 3D model.
  • The 3D model effectively captured the impact of USP37 downregulation on epithelial-mesenchymal transition (EMT) markers, correlating with reduced metastatic potential.
  • Carbon dot pH nanosensors provided sensitive and real-time data on cellular responses within the 3D microenvironment.

Conclusions:

  • The novel 3D cell culture system provides a rapid, reliable, and superior alternative to 2D models for studying cancer biology and evaluating therapeutic targets like USP37.
  • Targeting ubiquitin specific peptidase 37 (USP37) represents a promising therapeutic strategy for various cancers, supported by evidence from this advanced in vitro model.
  • This 3D platform facilitates mechanistic studies of oncogene function and drug response, accelerating the development of new cancer therapies.

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
835
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
753
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K